KalVista Pharmaceuticals Inc.
KALV | NASDAQ
$27
$0 (0.00%)
Jun 10, 2026, 4:00 PM ET · Market open
Fiscal Year Period Ending | FY 2026 Dec 30, 2025 | FY 2025 Apr 29, 2025 | FY 2024 Apr 29, 2024 | FY 2023 Apr 29, 2023 | FY 2022 Apr 29, 2022 | FY 2021 Apr 29, 2021 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 229.34M | 98.64M | 31.79M | 56.24M | 30.73M | 50.59M |
Short-Term Investments | 70.87M | 89M | 178.61M | 93.14M | 135.47M | 198.34M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 2.37M | 7.09M | 567K | 106K | 193K | 200K |
Receivables | 11.3M | 15.14M | 10.87M | 18.64M | 16.81M | 11.72M |
Inventory | 3.43M | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | 19.21M | n/a | n/a | n/a | n/a |
Total Current Assets | 320.15M | 241.69M | 225.69M | 172.33M | 193.65M | 264.26M |
Property-Plant & Equipment | 12.86M | 1.99M | 9.15M | 10.77M | 10.04M | 7.55M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 15.23M | 9.08M | 9.71M | 10.88M | 10.23M | 7.75M |
Total Assets | 335.38M | 250.77M | 235.4M | 183.2M | 203.88M | 272.01M |
Account Payables | 8.27M | 4.88M | 9.11M | 4.82M | 3.64M | 1.98M |
Deferred Revenue | n/a | 11M | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 36.8M | n/a | 6.69M | 4.21M | 4.17M | 3.51M |
Total Current Liabilities | 57.36M | 45.17M | 22.81M | 15.03M | 11.58M | 9.77M |
Long-Term Debt | 139.23M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 119.06M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 280.73M | 110.21M | 6.02M | 7.15M | 7.21M | 5.05M |
Total Liabilities | 338.09M | 155.38M | 28.82M | 22.18M | 18.79M | 14.82M |
Total Debt | 151.58M | 6.31M | 7.32M | 8.23M | 8.19M | 5.91M |
Book Value | -2.71M | 95.39M | 206.58M | 161.03M | 185.09M | 257.19M |
Book Value Per Share | -0.05 | 1.92 | 5.62 | 5.77 | 7.56 | 13.47 |
Common Stock | 51K | 50K | 42K | 34K | 25K | 24K |
Retained Earnings | -762.69M | -653.17M | -469.73M | -343.08M | -250.18M | -167.84M |
Comprehensive Income | -7.13M | -5.21M | -3.49M | -3.06M | -3.86M | -1.43M |
Shareholders Equity | -2.71M | 95.39M | 206.58M | 161.03M | 185.09M | 257.19M |
Total Investments | 70.87M | 89M | 178.61M | 93.14M | 135.47M | 198.34M |
Add to Watchlist
Select watchlists to add or remove KALV